NCT Number: NCT00360100
Zmax Pediatric Vs Adult Concentration For The Treatment Of Acute Otitis Media
Assess tolerability of different dosing formulations (adult versus pediatric).
Looking for future studies?
Notify MeKey information
Age range
3 month–48 month
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 3
Primary location
Pfizer Investigational Site, Córdoba, Córdoba Province, Argentina
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Have clinical signs/symptoms of AOM in at least 1 ear
Exclusion criteria
- Known or suspected hypersensitivity, or intolerance to azithromycin or other macrolides or to any penicillin, beta-lactam antibiotic or beta lactamase inhibitor
- Previously diagnosed disease(s) of immune function
- Treatment with any systemic (intravenous, intramuscular, oral) antibiotic for any indication within 7 days prior to enrollment
Treatment and study plan
Primary outcomes
-
Treatment-related vomiting on Day 1, which is based directly on the collected observed or voluntarily reported vomiting.
Secondary outcomes
-
Time-to-vomiting (in minutes) will be measured for all vomiting episodes that occur within the 60-minute observation period post-dosing on Day 1.
-
Frequency of the number of days of treatment-related vomiting by treatment group for subjects in the All Treated population.
-
Frequencies of occurrence, by day, of treatment-related vomiting.
-
Investigator and Sponsor assessment of clinical response.
Sponsors and collaborators
Lead sponsor
Pfizer
Industry
Registry information
Official study title
A Randomized, Multicenter, Comparative Study To Assess Tolerability Of A Single Oral 60 Mg/Kg Dose Of Zmax (Pediatric Concentration) Vs. Zmax (Adult Concentration) In Pediatric Patients With Acute Otitis Media
Important dates
- Study start
- 2006
- Study completion
- 2006
- First posted
- Aug 3, 2006
- Registry last updated
- May 17, 2011
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Treatment of Clogged Tympanostomy Tubes: An Off-Label Use of Dornase Alfa (Pulmozyme®)
NCT00419380
Ear Diseases, Otitis
Denver, Colorado, United States
View Trial DetailsDigital Otoscope Versus Education and Feedback for Otitis Media in Young Children
NCT06731660
Antimicrobial Stewardship, Ear Diseases
Wellesley, Massachusetts, United States
View Trial DetailsSystematic Search for Primary Immunodeficiency in Adults With Infections
NCT02972281
Antibody Deficiency, Bacterial Infections
Armentières, France
View Trial DetailsBroad Implementation of Outpatient Stewardship
NCT05127161
Acute Respiratory Tract Infection, Acute Sinusitis
Plantation, Florida, United States
View Trial Details